ABCG2 and gout: Although 4-PBA and colchicine are relatively non-specific agents, these relatively non-toxic molecules may have clinical value in the treatment of gout, and in fact, colchicine may at least partially evoke its beneficial effect in gout by increasing ABCG2 expression.